Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
ZIOPHARM Oncology
3861
ZIOPHARM Oncology
Technology
Biotechnology
ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies.
Suggest edits
Founded
2005
Raised
$177.5M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
Kickstarter
JPMorgan
Wired
Morgan Stanley
The New York Times
Companies in the same industry
Poietis
Apexian Pharmaceuticals
Aevi Genomic Medicine, Inc
Serstech
AptaTargets
Magnus Life Science
Storm Therapeutics
Cygnus Biosciences
Sun Genomics
resTORbio, Inc.
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$120,000,000
Post-IPO equity - 2016
$57,500,000
Post-IPO equity - 2015
Team Size
1–10
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
Xconomy
Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall
Health
The Motley Fool
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
The Motley Fool
Here's How Ziopharm Oncology Hopes to Win the CAR-T Race
The Motley Fool
Why Ziopharm Oncology Soared 49% In February
The Motley Fool
Why ZIOPHARM Oncology Inc. Published a Higher Stock Price Today
